Health Care and the Democratic Debates – Part 1 – Medicare For All, Rx Prices, Guns and Mental Health

Health Populi

Elizabeth Warren assertively and transparently backed Bernie Sander’s Medicare for All proposal. She is concerned about “kicking half of America off of health insurance in 4 years,” pivoting to the “much bigger issue” of pharmaceuticals pricing.

Health Care and the Democratic Debates – Round 2 – Battle Royale for M4All vs Medicare for All Who Want It – What It Means for Industry

Health Populi

Sanders, noting his call for big new government benefits like universal health care through Medicare for All and free college tuition. Senator Harris, too, mentioned government benefits like free college and Medicare for All as her health plan preference.

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. A study in JAMA published this week analyzed research reports that have measured waste in the U.S.

Patients Growing Health Consumer Muscles Expect Digital Services

Health Populi

Do not assume that older people, and especially “younger older” Medicare members between 65 and 74 don’t increasingly feel this way.

The New Drug Companies Aren’t Drug Companies At All

Health Populi

This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries.

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. published by the National Bureau of Economic Research found a close link between electoral politics and Medicare: that is, between legislative processes in the U.S. People in the U.S.

Social Determinants of Health – My Early Childhood Education and Recent Learnings, Shared at the HealthXL Global Gathering

Health Populi

To address this challenge, Medicare Advantage programs from Aetna and Humana are working with Papa which connects “grandchildren on demand” with older people to bolster social connections.

Costs, Consumerism, Cyber and Care, Everywhere – The 2019 Health Populi TrendCast

Health Populi

Greater attention paid to the social determinants of health, by payors (both public in Medicaid and Medicare, and in private sector benefit plans) will promote peoples’ access to care, services and social support outside of traditional, legacy healthcare nodes.

Talking “HealthConsuming” on the MM&M Podcast

Health Populi

Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019.

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. For people enrolled in Medicare Part D, 20% faced over $500 in OOP costs. Americans consumed 17.6

Technology, Aging and Obesity Drive Healthcare Spending, BEA Finds

Health Populi

Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S.

The United States of Diabetes: a $1,240 Tax on Every American

Health Populi

Pharmaceutical company executives are testifying in the U.S. The study analyzed medical claims for millions of patients, both commercially insured and enrolled in Medicare. Congress this week on the topic of prescription drug costs.

Most Americans Blame Drug Companies, Insurers, and Hospitals for High Health Care Costs

Health Populi

As for leveraging Medicare to cover more Americans as a cost-lowering strategy, health citizens are at-odds. Roughly one-half of people overall are concerned that Medicare will run out of money in the next decade.

In Wednesday’s second Democratic debate, 7 of 10 candidates support Medicare for All

Henry Kotula

Seven support Medicare for All. Unlike many of his Democratic rivals, Biden does not support full Medicare for All. As in Medicare, costs would be reduced through negotiating for lower prices from hospitals and other providers. [link].

Healthcare Is Local: Channeling Tip O’Neill in the 2018 Midterm Election Results

Health Populi

Democrats have been committed to the concept of the government negotiating drug prices directly with pharmaceutical companies the way other developed countries do. Doggett has been drafting legislation to allow the government such authority for drugs covered by Medicare Part D.

Prescription Drugs Are Becoming A Luxury Good in America – Join the #HCLDR Chat Tonight

Health Populi

But drug costs to patients are in the eye of the beholder, who in a high-deductible plan or Medicare Part D donut hole becomes the first-dollar payer.

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. That would be profits made by pharmaceutical companies, cited by 80% of respondents.

Americans Could Foster a Health Consumer Movement, Families USA Envisions

Health Populi

state), compensation for physicians by specialty (ranging from nearly one-half million dollars in orthopedics at the high end to a lower boundary of $212,000 for pediatrics), and inpatient payment for Medicare patients ranging from a high in San Francisco and a lower price in Youngstown, OH.

Two-Thirds of Americans Say Healthcare Doesn’t Work Well, in RealClear Politics Poll

Health Populi

They don’t tend to shop around for health care or be super-engaged in their care, probably because they tend to be older and more likely to be covered by Medicare. They may be threatened by a call for “Medicare for All” given their affection for the program.

Across All Political Parties, Likely Voters Over 50 Favor Cutting Prescription Drug Prices

Health Populi

It’s a rational response, then, that 9 in 10 older voters agree that pharmaceutical companies “make too much profits,” once again consistent — equally felt — by older voters across all three political parties, shown in the second bar chart.

Health Care for a Typical Working Family of Four in America Will Cost $28,166 in 2018

Health Populi

What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four?

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

Since the CVS+Aetna announcement last December, the Kaiser Family Foundation ran some numbers on how the merged organization could impact Medicare — a key payor for both health insurance and prescription drugs under Part D. CVS Health’s acquisition of Aetna was approved this week by U.S.

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

The report pointed especially to hospital and pharmaceutical prices. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure.

Self-Care is Healthcare for Everyday People

Health Populi

Note the new alliance between Walmart and Anthem to channel OTC meds to Medicare Advantage members). Patients are the new healthcare payors, and as such, taking on the role of health consumers.

As Medical Cost Trend Remains Flat, Patients Face Growing Health Consumer Financial Stress

Health Populi

Even with moderating medical trend growth, the Centers for Medicare and Medicaid Services (CMS) expect that healthcare spending will account for 20% of the U.S. When it comes to healthcare costs, lines that decline over time are generally seen as good news.

Prescription Drugs: From Costs and Bad Reputation to Civica Rx and Amazon to the Rescue

Health Populi

health consumers believe that Medicare should be allowed to negotiate with drug companies to fetch lower prices for prescription drugs, and that more drugs should switch to generic when possible. The prices of medicines prescribed in outpatient settings rose, on average. 10.3% in 2018.

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.

PCMA report says HHS rebate rule would significantly boost drug, Part D spending

FierceHealthIT

The Pharmaceutical Care Management Association released a statement calling the Health and Human Services’ proposed rule on prescription drug rebates for Medicare and Medicaid beneficiaries “poorly conceived

Will Foot Ulcer Treatment Survive Medicare Rollback?

Insulin Nation

A state-of-the-art wound therapy that prevents amputations is under threat from proposed cuts in Medicare reimbursement rates, according to regenerative medicine experts. Apligraf, pictured here, is a dressing made of living cells used to help heal diabetic foot ulcers.

Tech-Smart Seniors Have a Role To Play In Managing Rx Costs

Electronic Health Reporter

Pharmaceutical manufacturers face growing pressure from legislators, employers and consumers to control prescription drug costs, which have increased by as much as 15 percent between 2008 and 2016. Editorial Chris Hakim eHealth Medicare

Winners & Losers Amid CMS’ Prescription Drug Policy Changes

BHM Healthcare Solutions

Editor’s Note: Increasing costs for prescriptions is creating a long-term financial impact on Medicare Part D and its beneficiaries. Medicare-reliant drugmakers. ” Before, PBMs had no power to negotiate lower drug prices for Medicare Advantage or Part D plans.

Rising Drug Prices Immune to Market Forces

BHM Healthcare Solutions

Editor’s Note: Increasing costs for prescriptions is creating a long-term financial impact on Medicare Part D and its beneficiaries. Increasing costs for prescriptions is creating a long-term financial impact on Medicare Part D and its beneficiaries.

Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D

CMS.gov

Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D. Medicare Part D. Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D. Today the Centers for Medicare & Medicaid Services (CMS) announced proposed changes to Medicare Part D to lower prescription drug costs for beneficiaries. The changes we are proposing bring tools to Medicare that are widely used in private plans.

CMS' Verma touts value-based pricing—not negotiation—for high drug prices

FierceHealthIT

NEW YORK CITY—Centers for Medicare & Medicaid Services Administrator Seema Verma said the Trump administration wants to move forward on a value-based pricing approach to pharmaceuticals to help curb the high cost of drugs

Analysis shows frequent prescribers of opioids receive larger payments from pharma

FierceHealthIT

Doctors who write the most opioid prescriptions get paid the most money from the pharmaceutical companies that manufacture the drugs, an analysis by CNN and researchers at Harvard University found. Using government databases, the report found that 54% of doctors who wrote prescriptions to Medicare patients in 2014 and 2015 for opioids received a payment from pharmaceutical companies that make the drugs

150 top places to work in healthcare

Henry Kotula

For employees over 55 years old, the hospital offers free Medicare and health claims assistance. [link].

Lower Prescription Drug Prices – A Tri-Partisan Call Across America

Health Populi

The Kaiser Health Tracking Poll has measured this sentiment over time, with this survey (shown in the bar chart) from 2017 finding the vast majority of Americans favoring Federal government negotiation to lower prices of drugs for people on Medicare.

Large Employers’ Focus on Prescription Drugs: Costs, Coupons and Communication

Health Populi

Co-pay accumulators are being discussed across health plan types, including government-sponsored plans like Medicare along with commercial health insurance programs.

Lilly CEO Defends Profits Made on Insulin

Insulin Nation

There is a watchful eye on the drug prices set by pharmaceutical companies, especially after the public outcry that came when Martin Shkreli, the former CEO of Turing Pharmaceuticals, raised the price of the life-saving drug Daraprim over 5,000 percent.

Medical costs projected to increase 6% by 2020, says PwC

Henry Kotula

The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. For payers, it becomes important to benchmark the prices paid commercially against a common reference point such as Medicare. [link].